23.01.2022, 900 Zeichen
Valneva: Valneva SE, an Austrian/French specialty vaccine company, announced results from an initial laboratory study demonstrating that serum antibodies induced by three doses of Valneva’s inactivated COVID-19 vaccine candidate, VLA2001, neutralize the Omicron variant. Sera from 30 participants in the Phase 1/2 trial VLA2001-201 were used in a pseudovirus assay to analyze neutralization of the ancestral SARS-CoV-2 virus as well as the Delta and Omicron variants. All 30 samples (100%) presented neutralizing antibodies against the ancestral virus and Delta variant, and 26 samples (87%) presented neutralizing antibodies against the Omicron variant. The mean fold reduction of neutralization relative to the ancestral virus was 2.7-fold for Delta and 16.7-fold for Omicron.
Valneva: weekly performance:
(From the 21st Austria weekly https://www.boerse-social.com/21staustria (19/01/2022)
SportWoche Podcast #105: Lisa Reichkendler, mit ihrem Food Marketing und Peast Performance ev. zu einem Sportgeschichte-Riegel
1.
Valneva - Valneva Has a Specialist Travel Vaccine Business and is a Contractor to the US Military
Aktien auf dem Radar:Palfinger, Amag, SBO, Flughafen Wien, AT&S, Frequentis, EVN, EuroTeleSites AG, CA Immo, Erste Group, Mayr-Melnhof, S Immo, Uniqa, Bawag, Pierer Mobility, ams-Osram, Addiko Bank, Wiener Privatbank, SW Umwelttechnik, Oberbank AG Stamm, Kapsch TrafficCom, Agrana, Immofinanz, OMV, Österreichische Post, Strabag, Telekom Austria, VIG, Wienerberger, Warimpex, American Express.
Vienna International Airport
Die Flughafen Wien AG positioniert sich durch die geografische Lage im Zentrum Europas als eine der wichtigsten Drehscheiben zu den florierenden Destinationen Mittel- und Osteuropas. Der Flughafen Wien war 2016 Ausgangs- oder Endpunkt für über 23 Millionen Passagiere.
>> Besuchen Sie 68 weitere Partner auf boerse-social.com/partner